A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive

Summary

This is a first time in Asia (FTIA) study of GSK4771261 in healthy participants of Chinese, Japanese, and White/European ancestry. The study will test whether GSK4771261 is safe, well-tolerated, how it is processed in the body, and whether it triggers an immune response.

Timeline

Start

2026-05-15

Primary completion

2026-09-22

Completion

2026-09-22

Drugs

Indications